Publications by authors named "I H J T De Hingh"
Introduction: Screening for colorectal cancer has been implemented to improve cancer-specific survival. This study aims to compare patient- and tumor characteristics, treatment, and survival between patients with screen-detected and clinically detected synchronous colorectal peritoneal metastases (CPM) in a Dutch population-based cohort.
Methods: Data from the Netherlands Cancer Registry (NCR) were used.
Article Synopsis
- Diagnostic imaging is crucial for treating ovarian and colorectal cancer by helping choose the best treatment options and assessing risks associated with them.
- A joint guideline was created by multiple medical societies to address challenges in detecting and reporting peritoneal metastases, using literature reviews and consensus methods.
- The consensus outlines key recommendations for best practices in imaging techniques, ensuring effective communication of results, and supporting clinical decisions regarding operability and treatment monitoring in affected patients.
Article Synopsis
- The study aimed to assess treatment outcomes, overall survival (OS), and factors influencing OS in patients with T1 ampullary cancer, a rare type of gastrointestinal cancer.
- Out of 244 patients with clinical T1 ampullary cancer, 75% underwent surgery, but a significant number were found to have more advanced disease upon further examination.
- The results indicated a stark difference in survival based on disease classification, with poor prognostic factors including higher pathological N classification and poorly differentiated tumors, emphasizing the need for aggressive treatment like pancreatoduodenectomy for T1 cases.
Colorectal peritoneal metastases (CPM) are common in colorectal cancer patients. This article aims to provide GRADE guidelines for the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in two clinical situations: (1) To determine the value of adjuvant HIPEC for the prevention of CPM in high-risk colorectal cancer patients; (2) to determine the impact on survival of cytoreductive surgery and HIPEC followed by adjuvant systemic chemotherapy as compared to systemic chemotherapy alone in patients with CPM.
View Article and Find Full Text PDF